hero section gradient
15 handpicked stocks

Zero-Knowledge Economy

Discover a carefully curated selection of companies at the forefront of privacy-preserving cryptography. These stocks have been handpicked by our expert analysts for their potential to transform how data is used securely in the digital economy, without ever compromising confidentiality.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Concise analysis of the basket's total market capitalisation and implications for investors.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad market performance, reducing idiosyncratic risk.
  • Use this basket as a core, long-term holding rather than as a speculative, high-growth position.
  • Expect steady, long-term appreciation tendencies; avoid expecting explosive short-term gains.
Total Market Cap
  • ARQQ: $589.51M

  • CYBR: $25.55B

  • SNOW: $83.86B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The future of data belongs to those who can use it while protecting it. These companies are commercializing breakthrough cryptographic technologies like zero-knowledge proofs and homomorphic encryption that allow computation on sensitive data without ever exposing it, creating entirely new business models and market opportunities.

2

What You Need to Know

This theme represents a high-growth, technology-forward investment in the future of secure computation. As AI requires more sensitive data and privacy regulations tighten globally, these firms are positioned to provide the essential infrastructure for tomorrow's digital economy where privacy is paramount.

3

Why These Stocks

We've selected both pure-play innovators developing privacy-preserving cryptography and established technology leaders implementing these methods at scale. This balanced approach targets companies with defensible market positions in a rapidly expanding field where data security and privacy are becoming mission-critical.

Why You'll Want to Watch These Stocks

🔒

The Privacy Revolution

As data breaches make headlines and regulations tighten, companies that can secure data while still making it useful are uniquely positioned to dominate the next wave of tech growth.

🚀

AI's Secret Enablers

AI needs massive datasets to improve, but much of the world's most valuable data is confidential. These companies are solving this trillion-dollar problem with technology that unlocks data value without exposure.

🔍

Hidden Tech Gems

While everyone watches the big tech names, these specialized security innovators are quietly building the essential infrastructure for tomorrow's data economy, potentially delivering outsized returns.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions